Log in
NYSEAMERICAN:IMUC

ImmunoCellular Therapeutics Stock Forecast, Price & News

$0.30
0.00 (0.00 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.26
Now: $0.30
$0.30
50-Day Range N/A
52-Week Range
$0.26
Now: $0.30
$0.42
Volume10,852 shs
Average Volume9,950 shs
Market Capitalization$12.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
Read More
ImmunoCellular Therapeutics logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryBiotechnology
SectorMedical
Current SymbolNYSEAMERICAN:IMUC
CUSIP45253610
CIKN/A
Phone+1-818-2642300
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$12.58 million
Next Earnings DateN/A
OptionableNot Optionable
$0.30
0.00 (0.00 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IMUC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMUC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ImmunoCellular Therapeutics (NYSEAMERICAN:IMUC) Frequently Asked Questions

How were ImmunoCellular Therapeutics' earnings last quarter?

ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC) posted its quarterly earnings results on Monday, August, 13th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter.
View ImmunoCellular Therapeutics' earnings history
.

Who are some of ImmunoCellular Therapeutics' key competitors?

What other stocks do shareholders of ImmunoCellular Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ImmunoCellular Therapeutics investors own include Argos Therapeutics (ARGSQ), NightFood (NGTF), Inovio Pharmaceuticals (INO), CytRx (CYTR), XOMA (XOMA), MannKind (MNKD), SELLAS Life Sciences Group (SLS), Agenus (AGEN), Sarepta Therapeutics (srpt) and Chimerix (CMRX).

Who are ImmunoCellular Therapeutics' key executives?

ImmunoCellular Therapeutics' management team includes the following people:
  • Mr. Gary S. Titus, Chairman & Corp. Sec. (Age 58)
  • Dr. Anthony J. Gringeri, CEO, Pres & Director (Age 65)
  • Dr. John S. Yu, Founder & Director (Age 54)
  • Mr. David E. Fractor, Chief Financial Officer (Age 58)
  • Dr. Steven J. Swanson, Sr. VP of Research (Age 62)

What is ImmunoCellular Therapeutics' stock symbol?

ImmunoCellular Therapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IMUC."

How do I buy shares of ImmunoCellular Therapeutics?

Shares of IMUC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ImmunoCellular Therapeutics' stock price today?

One share of IMUC stock can currently be purchased for approximately $0.30.

How big of a company is ImmunoCellular Therapeutics?

ImmunoCellular Therapeutics has a market capitalization of $12.58 million.

What is ImmunoCellular Therapeutics' official website?

The official website for ImmunoCellular Therapeutics is imuc.com.

How can I contact ImmunoCellular Therapeutics?

ImmunoCellular Therapeutics' mailing address is 30721 Russell Ranch Rd Ste 140, WESTLAKE VILLAGE, CA 91362-7383, United States. The biotechnology company can be reached via phone at +1-818-2642300.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.